NCT04672967View on ClinicalTrials.gov

MAP Autism Prediction Study

UnknownOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

November 3, 2021

Primary Completion Date

May 31, 2022

Study Completion Date

October 31, 2022

Conditions
Autism Spectrum DisorderDevelopmental Delay
Interventions
DIAGNOSTIC_TEST

BioROSA MAP test

The BioROSA MAP test is a blood test that is being developed to predict ASD risk

Trial Locations (1)

37212

RECRUITING

VUMC, Nashville

Sponsors
All Listed Sponsors
collaborator

Melmed Center

UNKNOWN

collaborator

Vanderbilt University

OTHER

lead

BioROSA Technologies Inc

INDUSTRY